Introducing biomarkers for the management of patients with prostate cancer - European Medical Journal

Introducing biomarkers for the management of patients with prostate cancer

Oncology
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Eleni Efstathiou, MD, PhD, of The University of Texas MD Anderson Cancer Center, Houston, TX, reviews the progress of biomarker discovery and validation for informing clinical decision-making in the management of patients with prostate cancer.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally

>